Page last updated: 2024-09-05

colistimethate sodium and Pseudomonas Infections

colistimethate sodium has been researched along with Pseudomonas Infections in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (10.53)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (5.26)	29.6817
2010's	31 (81.58)	24.3611
2020's	1 (2.63)	2.80

Authors

Authors	Studies
Bilton, D; Caine, N; Charman, SC; Kaplan, S; Lee, A	1
Hickerson, WL; Hill, DM; Wilkinson, RE	1
Cao, W; Debonnett, L; Greenwood, J; Hamed, K; Mastoridis, P; Nash, EF; Schwarz, C; Sommerwerck, U; Tamm, M	1
Couet, W; Fron, D; Grégoire, N; Loiez, C; Magréault, S; Marchand, S; Nectoux, E; Petyt, C; Senneville, E	1
Buclin, T; Corti, N; Decosterd, L; Leuppi-Taegtmeyer, AB; Mueller, NJ; Osthoff, M	1
Cogen, JD; Goss, CH; Nichols, DP; Nick, JA; Nick, SE; Russell, R; Saavedra, MT; Somayaji, R; Taylor-Cousar, JL	1
Aanaes, K; Alanin, M; Hjuler, T; Johansen, HK; Skov, M; von Buchwald, C	1
Cantrell, A; Carroll, C; Harnan, S; Mildred, M; Tappenden, P; Uttley, L	1
Brownlee, K; Cantrell, A; Harnan, S; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M	1
Brownlee, K; Harnan, S; Mildred, M; Tappenden, P; Taylor, C; Uttley, L; Walshaw, M	1
Clark, P; Knight, H; Nolan, K	1
Kamei, LK; Lopes, CK; Rigatto, MH; Rocha, JL; Tuon, FF; Zavascki, AP	1
Conole, D; Keating, GM	1
Fujita, K; Goto, H; Hattori, T; Ito, N; Koike, N; Kumakura, S; Kuroda, M; Matsumoto, T; Miyake, T; Tajima, K; Yamaguchi, T	1
Fiel, SB	1
Tappenden, P; Uttley, L	1
Asensio, VJ; Bachiller, D; Esquisabel, A; Gainza, E; Moreno-Sastre, M; Pastor, M; Pedraz, JL; Pozo, AD; Sans, E; Viñas, M	1
Dasenbrook, EC; Konstan, MW; VanDevanter, DR	1
Heil, EL; Lowery, AV; Nicolau, DP; Thom, KA	1
Collie, D; Doherty, C; Glendinning, L; Govan, J; McLachlan, G; Tennant, P; Thornton, E; Wright, S	1
Agrawal, D; Chatterjee, S	1
Bachiller, D; Esquisabel, A; Moreno-Sastre, M; Pastor, M; Pedraz, JL; Sans, E; Viñas, M	1
Alvarez-Lerma, F; Benito, N; Campillo, N; Esteve, E; Grau, S; Herrera, S; Horcajada, JP; Luque, S; Montero, M; Segura, C; Sorlí, L	1
Celebi, S; Cetinkaya, M; Hacimustafaoglu, M; Koksal, N; Ozkan, H	1
Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY	1
Cho, E; Davidson, AG; Lillquist, YP	1
Celik, IH; Demirel, G; Dilmen, U; Erdeve, O; Oguz, SS	1
Accetta, G; Cusato, M; Del Gaudio, A; Imberti, R; Iotti, GA; Marinò, V; Procaccio, F; Regazzi, M	1
Angyalosi, G; Balp, MM; Capkun-Niggli, G; Doering, G; Higashi, K; Jansen, JP; Littlewood, KJ; Tiddens, HA	1
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT	1
Döring, G; Goldman, MH; Haliburn, C; Schuster, A	1
Fernández, AB; Pérez, M; Soto, L	1
MANN, PH	1
ARMENIA, JV; JONES, WY	1
BAINES, RD; RIFKIND, D	1
NIXON, M; RODGER, KC; TONNING, HO	1
McCoy, KS	1
Coulthard, K; Li, J; Milne, R; Nation, RL; Turnidge, J	1

Reviews

6 review(s) available for colistimethate sodium and Pseudomonas Infections

Article	Year
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model. Health technology assessment (Winchester, England), 2013, Volume: 17, Issue:56 Topics: Administration, Inhalation; Child; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Disease Progression; Humans; Outcome Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Therapeutic Equivalency; Tobramycin; United Kingdom	2013
Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis. European respiratory review : an official journal of the European Respiratory Society, 2013, Volume: 22, Issue:130 Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Disease Progression; Dry Powder Inhalers; Evidence-Based Medicine; Forced Expiratory Volume; Humans; Lung; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Research Design; Time Factors; Tobramycin; Treatment Outcome	2013
Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Drugs, 2014, Volume: 74, Issue:3 Topics: Chronic Disease; Colistin; Cystic Fibrosis; Drug Resistance, Bacterial; Dry Powder Inhalers; Humans; Lung; Pseudomonas aeruginosa; Pseudomonas Infections	2014
Aerosolized antibiotics in cystic fibrosis: an update. Expert review of respiratory medicine, 2014, Volume: 8, Issue:3 Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Aztreonam; Colistin; Cystic Fibrosis; Equipment Design; Humans; Levofloxacin; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Tobramycin	2014
Dry powder inhalers in cystic fibrosis: same old drugs but different benefits? Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:6 Topics: Administration, Inhalation; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Dry Powder Inhalers; Humans; Medication Adherence; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	2014
A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2012, Volume: 11, Issue:5 Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Load; Bayes Theorem; Biological Availability; Chronic Disease; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Information Services; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tobramycin; Treatment Outcome	2012

Trials

3 trial(s) available for colistimethate sodium and Pseudomonas Infections

Article	Year
Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection. Therapeutic advances in respiratory disease, 2017, Volume: 11, Issue:7 Topics: Administration, Inhalation; Adolescent; Adult; Anti-Bacterial Agents; Child; Colistin; Cross-Over Studies; Cystic Fibrosis; Equipment Contamination; Equipment Design; Europe; Female; Forced Expiratory Volume; Humans; Lung; Male; Nebulizers and Vaporizers; Patient Satisfaction; Powders; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome; Young Adult	2017
Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Chromatography, Liquid; Colistin; Continuous Renal Replacement Therapy; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Mass Spectrometry; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections	2019
Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study. Thorax, 2013, Volume: 68, Issue:4 Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Colistin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Powders; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome; Young Adult	2013

Other Studies

29 other study(ies) available for colistimethate sodium and Pseudomonas Infections

Article	Year
Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021, Volume: 20, Issue:2 Topics: Administration, Inhalation; Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Colistin; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Registries; Respiratory Tract Infections; Symptom Flare Up; United Kingdom	2021
Outcome analysis of colistin-treated burn center patients. Burns : journal of the International Society for Burn Injuries, 2017, Volume: 43, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Burn Units; Burns; Colistin; Creatinine; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Outcome Assessment, Health Care; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Replacement Therapy; Retrospective Studies; Treatment Failure	2017
Pharmacokinetics of colistin in a 8-year-old child with acute bone infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:9 Topics: Acute Disease; Anti-Bacterial Agents; Child; Colistin; Drug Administration Schedule; Humans; Male; Metabolic Clearance Rate; Osteomyelitis; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections	2018
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis. Annals of the American Thoracic Society, 2019, Volume: 16, Issue:7 Topics: Administration, Inhalation; Administration, Intravenous; Adult; Anti-Bacterial Agents; Azithromycin; Colistin; Cystic Fibrosis; Disease Progression; Female; Forced Expiratory Volume; Humans; Logistic Models; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Young Adult	2019
The effect of sinus surgery with intensive follow-up on pathogenic sinus bacteria in patients with cystic fibrosis. American journal of rhinology & allergy, 2013, Volume: 27, Issue:1 Topics: Achromobacter denitrificans; Adolescent; Adult; Burkholderia; Burkholderia Infections; Child; Chronic Disease; Colistin; Cystic Fibrosis; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Nasal Lavage; Paranasal Sinuses; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Rhinitis; Sinusitis; Treatment Outcome; Young Adult	2013
The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis. PharmacoEconomics, 2014, Volume: 32, Issue:2 Topics: Adult; Anti-Bacterial Agents; Colistin; Cost-Benefit Analysis; Cystic Fibrosis; Decision Support Techniques; Dry Powder Inhalers; Humans; Models, Economic; Pneumonia, Bacterial; Probability; Pseudomonas aeruginosa; Pseudomonas Infections; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Survival Analysis; Tobramycin; Young Adult	2014
NICE guidance on colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis. The Lancet. Respiratory medicine, 2013, Volume: 1, Issue:2 Topics: Administration, Inhalation; Anti-Bacterial Agents; Clinical Trials as Topic; Colistin; Cystic Fibrosis; Drug Monitoring; Drug Therapy, Combination; Dry Powder Inhalers; Humans; Practice Guidelines as Topic; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; State Medicine; Tobramycin; United Kingdom	2013
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium. International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Anti-Bacterial Agents; Cohort Studies; Colistin; Female; Hospital Mortality; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Vancomycin	2014
In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:6 Topics: Animals; Anti-Bacterial Agents; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits	2014
Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis. International journal of pharmaceutics, 2014, Dec-30, Volume: 477, Issue:1-2 Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Colistin; Cystic Fibrosis; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lipids; Mice; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Surface Properties; Tissue Distribution	2014
Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2015, Volume: 14, Issue:3 Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Anti-Bacterial Agents; Aztreonam; Child; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tobramycin; Treatment Outcome; Young Adult	2015
Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens. Pharmacotherapy, 2015, Volume: 35, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Heart-Assist Devices; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Time Factors; Treatment Outcome	2015
Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium. PloS one, 2015, Volume: 10, Issue:11 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Chronic Disease; Colistin; Disease Models, Animal; Female; Injections, Intravenous; Lung; Male; Microbiota; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sheep, Domestic	2015
Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate. Indian journal of ophthalmology, 2016, Volume: 64, Issue:2 Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Child; Colistin; Corneal Ulcer; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Visual Acuity	2016
Stability study of sodium colistimethate-loaded lipid nanoparticles. Journal of microencapsulation, 2016, Volume: 33, Issue:7 Topics: Colistin; Cystic Fibrosis; Drug Stability; Humans; Lipids; Nanoparticles; Pseudomonas aeruginosa; Pseudomonas Infections	2016
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC infectious diseases, 2017, 01-05, Volume: 17, Issue:1 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Availability; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Kidney Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Young Adult	2017
Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:3 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Child; Child, Preschool; Colistin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Hospitals, University; Humans; Infant; Infant, Newborn; Injections, Intravenous; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Male; Microbial Sensitivity Tests; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics, Nonparametric; Treatment Outcome; Turkey	2010
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient. Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	2010
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2011, Volume: 10, Issue:3 Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia complex; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Colistin; Cystic Fibrosis; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Health Care Costs; Health Resources; Humans; Infant; Injections, Intravenous; Nebulizers and Vaporizers; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	2011
Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review. European journal of pediatrics, 2012, Volume: 171, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Inhalation; Anti-Bacterial Agents; Colistin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Treatment Outcome	2012
Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:8 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Central Nervous System Bacterial Infections; Colistin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Injections, Intraventricular; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections	2012
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium. Pediatric pulmonology, 2013, Volume: 48, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Disease Progression; Female; Humans; Male; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult	2013
Sudden respiratory muscle paralysis and apnea in a patient infected with multidrug-resistant Pseudomonas aeruginosa treated with intravenous colistin. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:5 Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Apnea; Aztreonam; Colistin; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Paralysis	2013
A REPORT ON THE USE OF COLISTIMETHATE SODIUM IN A GENERAL HOSPITAL. Current therapeutic research, clinical and experimental, 1963, Volume: 5 Topics: Colistin; Enterobacter aerogenes; Enterococcus faecalis; Escherichia coli Infections; Hospitals, General; Humans; Proteus Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections	1963
EFFICACY OF COLISTIMETHATE SODIUM IN TREATMENT OF PSEUDOMONAS INFECTION. American journal of ophthalmology, 1963, Volume: 56 Topics: Colistin; Humans; Injections; Injections, Intramuscular; Keratoconjunctivitis; Neomycin; Ophthalmic Solutions; Penicillins; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Streptomycin	1963
INTRAVENOUS ADMINISTRATION OF SODIUM COLISTIMETHATE. JAMA, 1964, Oct-26, Volume: 190 Topics: Administration, Intravenous; Blood Chemical Analysis; Colistin; Creatine; Creatinine; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney Function Tests; Nitrogen; Pharmacology; Pneumonia; Probenecid; Pseudomonas Infections; Pyelonephritis; Sodium; Urea	1964
TREATMENT OF INFECTIONS WITH COLISTIMETHATE SODIUM (COLY-MYCIN). Canadian Medical Association journal, 1965, Jul-24, Volume: 93 Topics: Colistin; Drug Therapy; Enterobacter; Escherichia coli; Escherichia coli Infections; Geriatrics; Humans; Proteus; Pseudomonas Infections; Respiratory Tract Infections; Toxicology; Urinary Tract Infections	1965
Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome. The New England journal of medicine, 2007, 11-29, Volume: 357, Issue:22 Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Drug Compounding; Fatal Outcome; Female; Humans; Nebulizers and Vaporizers; Prodrugs; Pseudomonas Infections; Respiratory Distress Syndrome	2007
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:3 Topics: Anti-Bacterial Agents; Colistin; Cystic Fibrosis; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors	2001